SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Pluvia's Fist.com - Pluvia's Plays & Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: Pluvia who wrote (980)9/12/2000 10:39:40 PM
From: Valueman  Read Replies (1) | Respond to of 1766
 
The burden of proof is on you my friend. The trial results and reduction in viral loads are easily accessed at the Trimeris web site. The fast track status from the FDA and the progression through the trials of the approval process would indicate some efficacy with T-20. Do you believe the FDA is giving the go ahead to TRMS without doing their homework? I find that difficult to swallow.